Dec 23, 2008 - Teva today announced the launch of a new, thinner, 29-gauge pre-filled syringe for its multiple sclerosis treatment, COPAXONE (glatiramer acetate injection). A recent survey of 562 MS patients found the new thinner needle was significantly preferred by 77 percent of patients over the previous 27-gauge needle.
The details can be read here.
No comments:
Post a Comment